1. Home
  2. FUND vs RCEL Comparison

FUND vs RCEL Comparison

Compare FUND & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FUND
  • RCEL
  • Stock Information
  • Founded
  • FUND 1988
  • RCEL 2020
  • Country
  • FUND Canada
  • RCEL United States
  • Employees
  • FUND N/A
  • RCEL N/A
  • Industry
  • FUND Investment Managers
  • RCEL Medical/Dental Instruments
  • Sector
  • FUND Finance
  • RCEL Health Care
  • Exchange
  • FUND Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • FUND 230.3M
  • RCEL 274.7M
  • IPO Year
  • FUND N/A
  • RCEL N/A
  • Fundamental
  • Price
  • FUND $8.05
  • RCEL $11.95
  • Analyst Decision
  • FUND
  • RCEL Hold
  • Analyst Count
  • FUND 0
  • RCEL 3
  • Target Price
  • FUND N/A
  • RCEL $16.50
  • AVG Volume (30 Days)
  • FUND 32.5K
  • RCEL 75.6K
  • Earning Date
  • FUND 01-01-0001
  • RCEL 11-07-2024
  • Dividend Yield
  • FUND 6.64%
  • RCEL N/A
  • EPS Growth
  • FUND N/A
  • RCEL N/A
  • EPS
  • FUND 0.93
  • RCEL N/A
  • Revenue
  • FUND N/A
  • RCEL $60,040,000.00
  • Revenue This Year
  • FUND N/A
  • RCEL $40.31
  • Revenue Next Year
  • FUND N/A
  • RCEL $45.42
  • P/E Ratio
  • FUND $8.33
  • RCEL N/A
  • Revenue Growth
  • FUND N/A
  • RCEL 32.24
  • 52 Week Low
  • FUND $6.75
  • RCEL $7.51
  • 52 Week High
  • FUND $8.47
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • FUND 67.90
  • RCEL 65.36
  • Support Level
  • FUND $7.73
  • RCEL $10.05
  • Resistance Level
  • FUND $8.12
  • RCEL $12.64
  • Average True Range (ATR)
  • FUND 0.09
  • RCEL 0.58
  • MACD
  • FUND 0.03
  • RCEL 0.19
  • Stochastic Oscillator
  • FUND 82.93
  • RCEL 74.06

About FUND Sprott Focus Trust Inc.

Sprott Focus Trust Inc is a diversified closed-end investment company. Its primary investment objective is long-term capital growth. To achieve its objective, The Fund may invest its assets in equity securities and in direct obligations of the U.S. Government or its agencies and in the non-convertible preferred stocks & debt securities of domestic and foreign companies. It invests in various sectors, of which Materials, Financials, Energy, Information technology sector account for the majority weightage.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: